Drinking Water and Health,

Drinking Water and Health,

Volume 5

  • Publisher: National Academies Press
  • ISBN: 9780309033817
  • eISBN Pdf: 9780309573269
  • Place of publication:  United States
  • Year of digital publication: 1983
  • Month: January
  • Pages: 170
  • Language: English
  • Drinking Water and Health: Volume 5
  • Copyright
  • List of Participants
  • Preface
  • Contents
  • I Introduction
    • REFERENCES
  • II Toxicity of Selected Contaminants in Drinking Water
    • ALDICARB
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
    • CARBOFURAN
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • CARBON TETRACHLORIDE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • CHLOROBENZENE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
        • Conclusions and Recommendations
    • O-DICHLOROBENZENE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
    • P-DICHLOROBENZENE
      • Metabolism
      • Health Effects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • 1,2-DICHLOROETHANE
      • Metabolism
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • 1,1-DICHLOROETHYLENE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
    • 1,2-DICHLOROETHYLENE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • DICHLOROMETHANE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • DINOSEB
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
    • HEXACHLOROBENZENE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • METHOMYL
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
    • PICLORAM
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
    • ROTENONE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
    • TETRACHLOROETHYLENE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
        • Conclusions and Recommendations
    • 1,1,1-TRICHLOROETHANE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • TRICHLOROETHYLENE
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • VINYL CHLORIDE (MONOCHLOROETHYLENE)
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
    • URANIUM (U)
      • Metabolism
      • Health Aspects
        • Observations in Humans
        • Observations in Other Species
      • Conclusions and Recommendations
        • Suggested No-Adverse-Response Level (SNARL)
      • Conclusions
        • Chronic Toxicity
      • Research Recommendations
    • REFERENCES
  • III Epidemiology of the Adverse Health Effects of Arsenic and Asbestos in Drinking Water
    • ARSENIC
      • Conclusions and Recommendations
    • ASBESTOS
      • Background
      • Exposure to Asbestos from Drinking Water
      • Estimating the Cancer Risk from Swallowed Asbestos Following Occupational Exposure
        • Studies of Asbestos Workers
      • Converting Risk to Asbestos Workers to Risk from Swallowed Asbestos
        • Step 1: Measurement of Dose and Adoption of Risk Model
        • Step 2: Conversion of Dose of Asbestos Inhaled to Dose of Asbestos Swallowed
        • Step 3: Conversion of Number of Fibers Seen by Light Microscope to Number of Fibers Seen by Transmis ...
      • Predicting the Results of Epidemiological Studies of GI Cancer Risk from Asbestos-Contaminated Drink ...
      • Converting RR's to Lifetime GI Cancer Risks
      • Epidemiological Studies of Cancer Risk from Asbestos-Contaminated Drinking Water
        • Duluth
        • Connecticut
        • San Francisco Bay Area
        • Puget Sound Area
      • EPA Criteria Document Methodology
        • Step 1: Conversion of LM Fibers/ml Air to TEM Fibers Swallowed
        • Step 2: Conversion of LM Fibers/ml Air to TEM Fibers/Liter in Drinking Water for a 70-Year Exposure
        • Step 3: Conversion of TEM Fibers/Liter for 70 years to Additional Lifetime Cancer Risk per 100,000
      • Animal Experiments
      • Summary and Conclusions
    • REFERENCES
      • Arsenic
      • Asbestos
  • Appendix 1977 Amendment to the Safe Drinking Water Act
    • REFERENCE
  • Index

SUBSCRIBE TO OUR NEWSLETTER

By subscribing, you accept our Privacy Policy